What is the latest sales price of Apelvis in 2024?

Alpelisib is an important anticancer drug that is often used in combination with fulvestrant to treat a specific type of breast cancer that is common in menopausal women and in men whose cancers progress. This type of cancer is characterized by spread to nearby tissue or other parts of the body. The mechanism of action of Apelvis is that it can act as a kinase inhibitor, effectively blocking the reproduction signals of cancer cells, thereby inhibiting the further spread of cancer cells.

However, the original drug of Apelvis has not yet been launched in my country, so its price information is not transparent. This has caused many patients and their families to become extremely concerned about the cost of their treatment. Judging from the situation in overseas markets, the price of Apelis varies depending on the region and specifications. The price of Apelvis in the European market, which is 150mg*56 tablets, may be as high as more than 40,000 yuan. In contrast, the price of the same drug in the Indian market is lower, with the price of 150mg*28 tablets per box being more than 5,000 yuan. However, the specific price may vary depending on sales channels and exchange rate fluctuations.

In addition, generic drugs of Apelvis have also appeared in overseas markets, such as the products produced by Laos Pharmaceutical Factory, which are more affordable and have specificationsThe price of 150mg*28 tablets per box may be more than 2,000 yuan, but it is also affected by factors such as exchange rates. The quality and efficacy of generic Apelvis drugs are equivalent to those of the original drug, further reducing the financial burden on patients in terms of price.

Therefore, for domestic patients, since the original drug of Apelvis has not yet been launched in China, they may need to purchase this important therapeutic drug through overseas purchase. This undoubtedly increases the financial burden on patients and the uncertainty of treatment.